EUCTR2012-004048-31-FR进行中（未招募）1 期
Multicenter single-arm pilot study evaluating efficacy of nilotinib in CML patients with molecular relapse after Glivec discontinuation within the context of the STIM trials (STIM and STIM2), Nilo Post-STIM - Nilo Post-STIM
CHU de Bordeaux0 个研究点目标入组 70 人开始时间: 2021年1月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A study to about blinatumomab for patients with minimal residual disease (MRD) of acute lymphoblastic leukemiaPatients with minimal residual disease (MRD) positive B-precursor ALL with and without prior SCT documented after an interval of at least 8 days from last systemic chemo-therapy• at a level of =10-4 - <10-3 (molecular failure or molecular relapse) in an assay with a minimum sensitivity of 10-4 OR• at levels below 10-4 :o Positive <10-4, non quantifiable (MolNE1) ORo Positive <10-4 (MolNE2) OR• Presence of minimal residual disease (MRD), non quantifiable (MolNE3).MedDRA version: 21.1Level: LLTClassification code 10066104Term: Precursor B-lymphoblastic leukaemia acuteSystem Organ Class: 100000004864EUCTR2015-000733-76-DEGoethe-Universität Frankfurt, Universitätsklinikum, Med. Klinik II80
进行中（未招募）
1 期
A study in non-muscle invasive bladder cancer (CIS with or without papillary tumors) patients that failed to be clean 6 months after BCG therapy, and then join the study to treated by radiofrequency (microwave) technique combined with hyperthermia and the chemotherapy drug, Mitomycin C.on-Muscle-Invasive Bladder CancerEUCTR2016-000049-30-ESMedical Enterprises Europe B.V160
进行中（未招募）
1 期
A study in non-muscle invasive bladder cancer (CIS with or without papillary tumors) patients that failed to be clean 6 months after BCG therapy, and then join the study to treated by radiofrequency (microwave) technique combined with hyperthermia and the chemotherapy drug, Mitomycin C.on-Muscle-Invasive Bladder CancerEUCTR2016-000049-30-ATMedical Enterprises Europe B.V160
招募中
不适用
A study of apalutamide in metastatic castration-resistant prostate cancer patientsMetastatic Castration-resistant Prostate CancerJPRN-jRCTs051220077akano Yuzo110
已完成
3 期
Effect of Tildrakizumab in Patients with Moderate-to-Severe Plaque PsoriasisCTRI/2023/06/053784Sun Pharmaceutical Industries Limited115